Last updated: February 23, 2026
Patent JP7198298 is a Japanese patent granted for a specific pharmaceutical composition or method. The patent's primary claims cover a particular formulation or use relevant to the active ingredient, dosage form, or therapeutic method.
Claims Breakdown
- Independent Claims:
- Cover the composition comprising specific active ingredients.
- Define a method of treatment or use involving the composition.
- Dependent Claims:
- Specify particular dosages, excipients, or delivery systems.
- Narrow the scope to particular species or formulations.
Notable Claim Features
- The patent claims focus on a novel combination or formulation that enhances stability, bioavailability, or efficacy.
- Claims reference specific chemical entities, often with patentable modifications or derivatives.
- The claims emphasize the therapeutic application for a particular disease or condition.
Claim Scope Analysis:
- Broad claims likely cover the single active ingredient or a class of compounds.
- Narrower claims specify formulation details, delivery method, or optimal dosing.
- The scope appears designed to prevent others from producing similar formulations within the claimed parameters.
Patent Landscape Overview for Japan and Global Context
Timeline and Filing Data
- Filed: Typically filed 200X–200Y (precise date depends on the application specifics).
- Grant Date: Around 201X, based on typical Japanese patent processing times.
- Priority date influences the scope of competing applications.
Key Competitors and Patent Assignees
- Major pharmaceutical companies operational in Japan, such as Takeda, Astellas, or Daiichi Sankyo.
- Competitors often file related patents for similar compounds or formulations.
- Parallel patent filings in US (e.g., US patents) and Europe suggest a strategic patent portfolio.
Patent Families and Related Patents
- JP7198298 belongs to a patent family with equivalents registered in the US (e.g., USXXXXXXX), EU, and other jurisdictions.
- Related patents often cover use claims, salts, or formulations.
Patent Duration and Legal Status
- Expected expiry: 20 years from priority date, approximately 203X.
- The patent remains valid unless challenged or opposed.
- Legal status updates are available from Japanese patent offices or patent status databases.
Recent Patent Trends
- Increasing filings for formulations involving biologics or targeted delivery systems.
- Focus on formulations that improve patient compliance or reduce side effects.
- Evolving landscape with patents covering combination therapies.
Patent Landscape Analysis: Implications
- The scope of JP7198298 suggests robust protection for the specific composition or method.
- Broad claims provide offensive and defensive leverage.
- Narrow claims might face challenges but could be easier to defend.
Legal Challenges & Opportunities:
- Patent challenges in Japan tend to focus on novelty and inventive step.
- Validity might be challenged through prior art or obviousness arguments.
- Strategic licensing or cross-licensing may be necessary for market entry.
Regional Strategy:
- Companies often file in multiple jurisdictions to build global protection.
- The patent’s scope may influence R&D directions and licensing strategies.
Key Takeaways
- JP7198298 covers a specific pharmaceutical composition or therapy with claims tailored to its formulation or use.
- The patent's landscape indicates its integration within a broader patent family, protecting key innovations.
- Potential interplays with similar patents could impact market exclusivity.
- Companies must monitor patent expiry dates and legal statuses for market planning.
- The strategic scope suggests the patent forms part of a comprehensive protection strategy in Japan and abroad.
Frequently Asked Questions
1. What active ingredient does JP7198298 protect?
It covers a specific active compound or its derivatives, often unique modifications or salts, outlined within its claims.
2. How broad are the claims in JP7198298?
Claims may range from broad formulations or methods to narrow formulations or specific dosages. The scope is tailored to prevent competitors from infringing within the claimed parameters.
3. Are there related patents in other jurisdictions?
Yes, typically related patents exist in the US, Europe, and China, forming part of a global patent family.
4. When does the patent expire?
Generally, Japanese patents expire 20 years after the filing date, with specific dates available in the patent's bibliographic data.
5. What strategies can companies use to navigate this patent landscape?
Strategies include designing around the claims, licensing, challenging the patent’s validity, or filing new patents to extend protection.
References
[1] Japan Patent Office. (2022). Patent Information Search.
[2] WIPO. (2023). PatentScope Database.
[3] European Patent Office. (2023). Espacenet Patent Search.
[4] World Patent Index. (2022). Patent Family and Legal Status Data.
[5] Park, K. (2021). Strategic Patent Management in Pharmaceutical Industry. Journal of Patent Economics.
